Diamedica Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.617; its P/E ratio is -4.21; Diamedica Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -5.14M	$ -4.46M	$ -4.47M	$ -5.26M	$ -3.74M
EBITDA	$ -5.13M	$ -4.46M	$ -4.46M	$ -5.26M	$ -3.74M
Net Income Common Stockholders	$ -5.16M	$ -4.47M	$ -4.48M	$ 5.77M	$ -3.75M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 52.90M	$ 46.47M	$ 40.37M	$ 28.66M	$ 33.50M
Total Assets	$ 54.16M	$ 58.14M	$ 62.05M	$ 30.08M	$ 34.40M
Total Debt	$ 400.00K	$ 420.00K	$ 440.00K	$ 459.00K	$ 469.00K
Net Debt	$ -52.49M	$ -46.05M	$ -39.93M	$ -28.20M	$ -33.03M
Total Liabilities	$ 3.10M	$ 2.51M	$ 2.31M	$ 3.19M	$ 2.57M
Stockholders Equity	$ 51.06M	$ 55.63M	$ 59.74M	$ 27.02M	$ 31.83M
Cash Flow	-
Free Cash Flow	$ -3.81M	$ -4.81M	$ -5.03M	$ -5.10M	$ -2.80M
Operating Cash Flow	$ -3.81M	$ -4.80M	$ -5.03M	$ -5.09M	$ -2.77M
Investing Cash Flow	$ 6.12M	$ 1.20M	$ -28.13M	$ 2.51M	$ 4.72M
Financing Cash Flow	$ -1.00K	$ -6.00K	$ 36.85M	$ -1.00K	$ -1.00K

Currency in USD

Diamedica Therapeutics Earnings and Revenue History

Income Statement >

Diamedica Therapeutics Debt to Assets

Balance Sheet >

Diamedica Therapeutics Cash Flow

Cash Flow >

Diamedica Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing